The changing therapeutic landscape of castration-resistant prostate cancer

被引：0
|
作者：
Timothy A. Yap
Andrea Zivi
Aurelius Omlin
Johann S. de Bono
机构：
[1] Drug Development Unit,
[2] The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research,undefined
来源：
Nature Reviews Clinical Oncology | 2011年 / 8卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment options for patients with castration-resistant prostate cancer are rapidly increasing, offering these patients hope of better quality of life and longer disease-free periods. This Review discusses the recent advances, the pitfalls and outlines a new treatment paradigm for the future.
引用
收藏
页码：597 / 610
页数：13
相关论文
共 50 条
  • [1] The changing therapeutic landscape of castration-resistant prostate cancer
    Yap, Timothy A.
    Zivi, Andrea
    Omlin, Aurelius
    de Bono, Johann S.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (10) : 597 - 610
  • [2] The changing landscape in metastatic castration-resistant prostate cancer
    Leibowitz-Amit, Raya
    Joshua, Anthony M.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 243 - 248
  • [3] The changing landscape in the treatment of metastatic castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (01) : 25 - 40
  • [4] Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel
    Fernandez, Ovidio
    Afonso, Javier
    Vazquez, Sergio
    Campos, Begona
    Lazaro, Matin
    Leon, Luis
    Anton Aparicio, Luis M.
    ANTI-CANCER DRUGS, 2014, 25 (03) : 237 - 243
  • [5] The changing landscape of hormonal therapy in castration-resistant prostate cancer
    Dongre, Amol
    Prabhash, Kumar
    Noronha, Vanita
    SOUTH ASIAN JOURNAL OF CANCER, 2012, 1 (02) : 53 - 55
  • [6] PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer: Unraveling the Therapeutic Landscape
    Al-Akhras, Ashaar
    Chehade, Chadi Hage
    Narang, Arshit
    Swami, Umang
    LIFE-BASEL, 2024, 14 (02):
  • [7] The mutational landscape of lethal castration-resistant prostate cancer
    Grasso, Catherine S.
    Wu, Yi-Mi
    Robinson, Dan R.
    Cao, Xuhong
    Dhanasekaran, Saravana M.
    Khan, Amjad P.
    Quist, Michael J.
    Jing, Xiaojun
    Lonigro, Robert J.
    Brenner, J. Chad
    Asangani, Irfan A.
    Ateeq, Bushra
    Chun, Sang Y.
    Siddiqui, Javed
    Sam, Lee
    Anstett, Matt
    Mehra, Rohit
    Prensner, John R.
    Palanisamy, Nallasivam
    Ryslik, Gregory A.
    Vandin, Fabio
    Raphael, Benjamin J.
    Kunju, Lakshmi P.
    Rhodes, Daniel R.
    Pienta, Kenneth J.
    Chinnaiyan, Arul M.
    Tomlins, Scott A.
    NATURE, 2012, 487 (7406) : 239 - 243
  • [8] The mutational landscape of lethal castration-resistant prostate cancer
    Catherine S. Grasso
    Yi-Mi Wu
    Dan R. Robinson
    Xuhong Cao
    Saravana M. Dhanasekaran
    Amjad P. Khan
    Michael J. Quist
    Xiaojun Jing
    Robert J. Lonigro
    J. Chad Brenner
    Irfan A. Asangani
    Bushra Ateeq
    Sang Y. Chun
    Javed Siddiqui
    Lee Sam
    Matt Anstett
    Rohit Mehra
    John R. Prensner
    Nallasivam Palanisamy
    Gregory A. Ryslik
    Fabio Vandin
    Benjamin J. Raphael
    Lakshmi P. Kunju
    Daniel R. Rhodes
    Kenneth J. Pienta
    Arul M. Chinnaiyan
    Scott A. Tomlins
    Nature, 2012, 487 : 239 - 243
  • [9] New Therapeutic Strategies for Castration-Resistant Prostate Cancer
    Tanaka, Tomoaki
    Nakatani, Tatsuya
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2011, 6 (03) : 373 - 383
  • [10] Therapeutic Effect of Ethinylestradiol in Castration-resistant Prostate Cancer
    Nakano, Taito
    Kadono, Yoshifumi
    Iwamoto, Hiroaki
    Yaegashi, Hiroshi
    Iijima, Masashi
    Kawaguchi, Shohei
    Nohara, Takahiro
    Shigehara, Kazuyoshi
    Izumi, Kouji
    Mizokami, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (04) : 2291 - 2296
12345